This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lossdörfer, S. Articles by Jäger, A. Search for Related Content PubMed PubMed Citation Articles by Lossdörfer, S. Articles by Jäger, A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB PARATHYROID HORMONE Social Bookmarking                         What's this?

PTH(1-34) Affects Osteoprotegerin Production in Human PDL Cells in vitro

Department of Orthodontics, Dental Clinic, University of Bonn, Welschnonnenstr. 17, 53111 Bonn, Germany;

View larger version (34K): [in this window] [in a new window]   Figure 1. Effect of PTH(1-34) treatment on regulation of cell number in confluent and pre-confluent PDL cells. Cells were either treated intermittently with 10–12 M PTH(1-34) for 0, 1, 3, 6, or 24 hrs during 3 cycles of 48 hrs each, or were exposed continuously (cont). Data were acquired from one of two separate experiments, both yielding comparable results. Each value is the mean ± SEM for 6 independent cultures. *P < 0.05, experimental group vs. untreated control. #P < 0.05, experimental group vs. PTH(1-34) for 1 hr/cycle; •P < 0.05, experimental group vs. PTH(1-34) for 3 hrs/cycle.

View larger version (32K): [in this window] [in a new window]   Figure 2. Decrease in osteocalcin production in confluent PDL cells following intermittent and continuous exposure to PTH(1-34) as opposed to a significant increase in response to 1 hr/cycle challenge in pre-confluent cells. Cells were either treated intermittently with 10–12 M PTH(1-34) for 0, 1, 3, 6, or 24 hrs during 3 cycles of 48 hrs each, or were challenged continuously (cont). Data were acquired from one of two separate experiments, both yielding comparable results. Each value is the mean ± SEM for 6 independent cultures. *P < 0.05, experimental group vs. untreated control; #P < 0.05, experimental group vs. PTH(1-34) for 1 hr, 3 hrs, 6 hrs/cycle.

View larger version (43K): [in this window] [in a new window]   Figure 3. PTH (1-34) effect on OPG expression and production. (A) Serving as an example, the RT-PCR for OPG, RANKL, and GAPDH following PTH exposure of confluent PDL cells from one out of six donors is depicted. (B) Biphasic reduction of OPG mRNA expression following intermittent PTH(1-34) challenge of confluent PDL cells, as compared with no effect in pre-confluent PDL cells. PDL cells were treated intermittently with 10–12 M PTH(1-34) for 0, 1, 3, 6, or 24 hrs during 3 cycles of 48 hrs each, or were exposed continuously (cont). Data were taken from one of two separate experiments, both yielding comparable results. Each value is the mean ± SEM for 6 independent cultures. *P < 0.05, experimental group vs. untreated control; #P < 0.05, experimental group vs. PTH(1-34) for 1 hr/cycle; •P < 0.05, experimental group vs. PTH(1-34) for 6 hrs/cycle. (C) Time-dependent reduction in OPG protein levels in response to intermittent PTH(1-34) challenge of confluent PDL cells. In contrast, there was an increase in OPG protein production following intermittent PTH(1-34) exposure for 6 hrs/cycle, and also after continuous treatment in pre-confluent cells. PDL cells were treated intermittently with 10–12 M PTH(1-34) for 0, 1, 3, 6, or 24 hrs during 3 cycles of 48 hrs each, or were exposed continuously (cont). *P < 0.05, experimental group vs. untreated control; #P < 0.05, experimental group vs. intermittent PTH(1-34) exposure.

Journal of Dental Research, Vol. 84, No. 7, 634-638 (2005)
DOI: 10.1177/154405910508400710


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?